Epilepsy in 1p36 Deletion Syndrome Is Not Associated with Deletion Size

Abstract

1p36 deletion syndrome is the most common subtelomeric deletion syndrome. The main clinical features are intellectual disability, characteristic craniofacial features, and epilepsy. Recent analysis revealed that a minimum deletion of 2.2 Mb from the telomere is essential for full manifestations of 1p36 deletion syndrome. Generally, severity of neurological symptoms in patients with 1p36 deletion syndrome correlates with the size of the deletion; however, the incidence of epilepsy does not correlate with deletion size. Some patients with minimum deletions never show symptoms of epilepsy, but there are patients who manifest intractable epilepsy, especially epileptic spasms. This evidence indicates that the responsible region for epilepsy is in the minimum deletion region, but the penetrance of epilepsy is not complete. Prognosis of brain development in patients with 1p36 deletions is related to the outcome of epilepsy treatment. Careful follow-up for infantile patients with 1p36 deletion syndrome would be recommended for early diagnosis and intervention for epilepsy.

Keywords

1p36 deletion syndrome - epilepsy - incidence - KCNAB2 - GABRD

• References

• 1 Heilstedt HA, Ballif BC, Howard LA, Kashork CD, Shaffer LG. Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality. Clin Genet 2003; 64 (4) 310-316
• 2 Shao L, Shaw CA, Lu XY , et al. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases. Am J Med Genet A 2008; 146A (17) 2242-2251
• 3 Shapira SK, McCaskill C, Northrup H , et al. Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 1997; 61 (3) 642-650
• 4 Heilstedt HA, Ballif BC, Howard LA , et al. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 2003; 72 (5) 1200-1212
• 5 Kurosawa K, Kawame H, Okamoto N , et al. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome. Brain Dev 2005; 27 (5) 378-382
• 6 Buck A, du Souich C, Boerkoel CF. Minimal genotype—phenotype correlation for small deletions within distal 1p36. Am J Med Genet A 2011; 155A (12) 3164-3169
• 7 Rosenfeld JA, Crolla JA, Tomkins S , et al. Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am J Med Genet A 2010; 152A (8) 1951-1959
• 8 Battaglia A, Hoyme HE, Dallapiccola B , et al. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008; 121 (2) 404-410
• 9 Shimada S, Shimojima K, Okamoto N , et al. Microarray analysis of 50 patients reveals the critical chromosomal regions responsible for 1p36 deletion syndrome-related complications. Brain Dev 2015; 37 (5) 515-526
• 10 Perkowski JJ, Murphy GG. Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability. J Neurosci 2011; 31 (1) 46-54
• 11 Dibbens LM, Feng HJ, Richards MC , et al. GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 2004; 13 (13) 1315-1319
• 12 Knight-Jones E, Knight S, Heussler H, Regan R, Flint J, Martin K. Neurodevelopmental profile of a new dysmorphic syndrome associated with submicroscopic partial deletion of 1p36.3. Dev Med Child Neurol 2000; 42 (3) 201-206
• 13 Saito Y, Kubota M, Kurosawa K , et al. Polymicrogyria and infantile spasms in a patient with 1p36 deletion syndrome. Brain Dev 2011; 33 (5) 437-441